(2)
The laboratory obtained funding of €350,000 from the French National Research Agency (ANR).
Lyon, 18 December 2020 - Theranexus, a biopharmaceutical company innovating in the treatment of neurological diseases has announced the creation and funding of a new joint public/private laboratory in partnership with the BIORAN team from the Lyon Neuroscience Research Center (CRNL) and CERMEP (Hospices Civils de Lyon, Claude Bernard Lyon 1 University, INSERM, CNRS), the regional biomedical imaging core dedicated to clinical and basic research.
This laboratory, NeuroImaging for Drug Discovery (NI2D) , aims to improve understanding of the cellular and molecular mechanisms of drug candidates developed by Theranexus - in particular at the neuronal and astrocyte level - using novel preclinical neuroimaging tools.
Semi-transparent dye-sensitized solar module with 8.7% efficiency
The mini-panel showed a short circuit current of 58.1 mA, an open circuit voltage of 3.63 V, and a fill factor of 58.26%. It has a power output is 122.9 mW and an active area of 14 cm2.Scientists in France have built a semi-transparent dye-sensitized mini solar panel with an active area of 14 cm2 based on benzothiadiazole-based photosensitizers. The research team, led by France s Molecular Systems and Nanomaterials for Energy and Health Laboratory (SyMMES) and the French Alternative Energies and Atomic Energy Commission (CEA), developed four different variants of a dye call RK1 that contains .
Den vollständigen Artikel lesen .